ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

GW Pharmaceuticals Limited

GW Pharmaceuticals Limited is an active company incorporated on 15 February 2001 with the registered office located in Cambridge, Cambridgeshire. GW Pharmaceuticals Limited was registered 24 years ago.
Status
Active
Active since incorporation
Company No
04160917
Private limited company
Age
24 years
Incorporated 15 February 2001
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Submitted
Dated 15 February 2025 (8 months ago)
Next confirmation dated 15 February 2026
Due by 1 March 2026 (3 months remaining)
Last change occurred 2 years 8 months ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
Sovereign House Vision Park, Chivers Way
Histon
Cambridge
CB24 9BZ
England
Same address for the past 4 years
Telephone
01223266800
Email
Available in Endole App
People
Officers
4
Shareholders
1
Controllers (PSC)
1
Director • Assistant General Counsel, Global Esg • French • Lives in England • Born in Sep 1981
Director • British • Lives in England • Born in Jan 1976
Director • Irish • Lives in England • Born in Aug 1971
Secretary
Jazz Pharmaceuticals UK Holdings Limited
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Jazz Pharmaceuticals Research UK Limited
David James Spackman is a mutual person.
Active
Jazz Pharmaceuticals Operations UK Limited
David James Spackman is a mutual person.
Active
Jazz Pharmaceuticals UK Limited
David James Spackman is a mutual person.
Active
Jazz Pharmaceuticals UK Holdings Limited
David James Spackman is a mutual person.
Active
GW UK Services Limited
David James Spackman is a mutual person.
Dissolved
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£999.9M
Decreased by £81.1M (-8%)
Total Liabilities
-£2.95M
Decreased by £975K (-25%)
Net Assets
£996.94M
Decreased by £80.13M (-7%)
Debt Ratio (%)
0%
Decreased by 0.07% (-19%)
Latest Activity
Full Accounts Submitted
1 Month Ago on 30 Sep 2025
Confirmation Submitted
8 Months Ago on 18 Feb 2025
Ms Amanda Flanagan Appointed
9 Months Ago on 10 Feb 2025
Nelly Alexandra Armissoglio ÉP. Lepelletier Resigned
9 Months Ago on 10 Feb 2025
New Charge Registered
11 Months Ago on 26 Nov 2024
Full Accounts Submitted
1 Year Ago on 12 Oct 2024
Aislinn Jane Doody Resigned
1 Year 7 Months Ago on 3 Apr 2024
Alkesh Patel Appointed
1 Year 7 Months Ago on 3 Apr 2024
Confirmation Submitted
1 Year 8 Months Ago on 19 Feb 2024
New Charge Registered
1 Year 9 Months Ago on 19 Jan 2024
Get Credit Report
Discover GW Pharmaceuticals Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Full accounts made up to 31 December 2024
Submitted on 30 Sep 2025
Confirmation statement made on 15 February 2025 with no updates
Submitted on 18 Feb 2025
Appointment of Ms Amanda Flanagan as a director on 10 February 2025
Submitted on 12 Feb 2025
Termination of appointment of Nelly Alexandra Armissoglio ÉP. Lepelletier as a director on 10 February 2025
Submitted on 10 Feb 2025
Registration of charge 041609170004, created on 26 November 2024
Submitted on 27 Nov 2024
Full accounts made up to 31 December 2023
Submitted on 12 Oct 2024
Appointment of Alkesh Patel as a secretary on 3 April 2024
Submitted on 18 Apr 2024
Termination of appointment of Aislinn Jane Doody as a secretary on 3 April 2024
Submitted on 18 Apr 2024
Confirmation statement made on 15 February 2024 with no updates
Submitted on 19 Feb 2024
Registration of charge 041609170003, created on 19 January 2024
Submitted on 23 Jan 2024
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year